nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—CYP2B6—malignant glioma	0.538	0.603	CbGaD
Ketobemidone—PTGS1—malignant glioma	0.354	0.397	CbGaD
Ketobemidone—CYP3A4—Temozolomide—malignant glioma	0.00362	1	CbGbCtD
Ketobemidone—Pethidine—CYP2B6—malignant glioma	0.0021	0.54	CrCbGaD
Ketobemidone—Pethidine—SLC6A3—malignant glioma	0.00179	0.46	CrCbGaD
Ketobemidone—OPRM1—telencephalic ventricle—malignant glioma	0.000806	0.227	CbGeAlD
Ketobemidone—OPRD1—telencephalon—malignant glioma	0.000284	0.0798	CbGeAlD
Ketobemidone—OPRM1—brainstem—malignant glioma	0.000218	0.0613	CbGeAlD
Ketobemidone—PTGS1—endothelium—malignant glioma	0.000211	0.0593	CbGeAlD
Ketobemidone—PTGS1—blood vessel—malignant glioma	0.000195	0.0547	CbGeAlD
Ketobemidone—OPRM1—telencephalon—malignant glioma	0.000194	0.0544	CbGeAlD
Ketobemidone—OPRD1—central nervous system—malignant glioma	0.000161	0.0453	CbGeAlD
Ketobemidone—OPRK1—central nervous system—malignant glioma	0.000155	0.0435	CbGeAlD
Ketobemidone—OPRK1—cerebellum—malignant glioma	0.000151	0.0425	CbGeAlD
Ketobemidone—OPRM1—midbrain—malignant glioma	0.000139	0.0391	CbGeAlD
Ketobemidone—OPRM1—spinal cord—malignant glioma	0.000136	0.0381	CbGeAlD
Ketobemidone—OPRD1—brain—malignant glioma	0.000128	0.036	CbGeAlD
Ketobemidone—OPRK1—brain—malignant glioma	0.000123	0.0345	CbGeAlD
Ketobemidone—OPRM1—central nervous system—malignant glioma	0.00011	0.0309	CbGeAlD
Ketobemidone—PTGS1—telencephalon—malignant glioma	9.44e-05	0.0265	CbGeAlD
Ketobemidone—OPRM1—brain—malignant glioma	8.73e-05	0.0245	CbGeAlD
Ketobemidone—PTGS1—spinal cord—malignant glioma	6.61e-05	0.0186	CbGeAlD
Ketobemidone—CYP2B6—central nervous system—malignant glioma	5.93e-05	0.0167	CbGeAlD
Ketobemidone—PTGS1—central nervous system—malignant glioma	5.37e-05	0.0151	CbGeAlD
Ketobemidone—CYP2C8—brain—malignant glioma	5.25e-05	0.0148	CbGeAlD
Ketobemidone—CYP2B6—brain—malignant glioma	4.71e-05	0.0132	CbGeAlD
Ketobemidone—CYP3A4—central nervous system—malignant glioma	4.48e-05	0.0126	CbGeAlD
Ketobemidone—PTGS1—brain—malignant glioma	4.26e-05	0.012	CbGeAlD
Ketobemidone—OPRM1—Signaling Pathways—PTK2—malignant glioma	1.71e-05	0.000175	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—BCAN—malignant glioma	1.7e-05	0.000175	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCL8—malignant glioma	1.7e-05	0.000174	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PDGFB—malignant glioma	1.7e-05	0.000174	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.7e-05	0.000174	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—FGFR1—malignant glioma	1.69e-05	0.000173	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTT1—malignant glioma	1.69e-05	0.000173	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HES1—malignant glioma	1.68e-05	0.000172	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CD80—malignant glioma	1.67e-05	0.000172	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CG—malignant glioma	1.67e-05	0.000171	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—APC—malignant glioma	1.67e-05	0.000171	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NCOR1—malignant glioma	1.67e-05	0.000171	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HIF1A—malignant glioma	1.66e-05	0.000171	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CAV1—malignant glioma	1.66e-05	0.00017	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—NCOR1—malignant glioma	1.66e-05	0.00017	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGF—malignant glioma	1.65e-05	0.000169	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—RAF1—malignant glioma	1.65e-05	0.000169	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTPN11—malignant glioma	1.64e-05	0.000168	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—IL2—malignant glioma	1.62e-05	0.000167	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CAV1—malignant glioma	1.61e-05	0.000165	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CB—malignant glioma	1.61e-05	0.000165	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.6e-05	0.000164	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.6e-05	0.000164	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PDGFRA—malignant glioma	1.6e-05	0.000164	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KDR—malignant glioma	1.59e-05	0.000163	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.59e-05	0.000163	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS1—malignant glioma	1.58e-05	0.000162	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.57e-05	0.000161	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—BRAF—malignant glioma	1.57e-05	0.000161	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SPP1—malignant glioma	1.55e-05	0.000159	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCL8—malignant glioma	1.54e-05	0.000158	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.54e-05	0.000158	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—F2—malignant glioma	1.53e-05	0.000157	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—FN1—malignant glioma	1.53e-05	0.000157	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT2—malignant glioma	1.53e-05	0.000157	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—EGFR—malignant glioma	1.52e-05	0.000156	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CG—malignant glioma	1.51e-05	0.000155	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—BAD—malignant glioma	1.51e-05	0.000155	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTT1—malignant glioma	1.51e-05	0.000154	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NOTCH1—malignant glioma	1.5e-05	0.000154	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL2—malignant glioma	1.48e-05	0.000151	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TERT—malignant glioma	1.47e-05	0.000151	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CD—malignant glioma	1.47e-05	0.000151	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—BCHE—malignant glioma	1.47e-05	0.000151	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CD80—malignant glioma	1.47e-05	0.000151	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—APC—malignant glioma	1.47e-05	0.00015	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CG—malignant glioma	1.47e-05	0.00015	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PPARG—malignant glioma	1.46e-05	0.00015	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.46e-05	0.000149	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—PIK3CA—malignant glioma	1.46e-05	0.000149	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.45e-05	0.000149	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGF—malignant glioma	1.45e-05	0.000149	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTPN11—malignant glioma	1.44e-05	0.000148	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—KRAS—malignant glioma	1.44e-05	0.000147	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PDGFB—malignant glioma	1.43e-05	0.000147	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—FGFR1—malignant glioma	1.43e-05	0.000146	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS1—malignant glioma	1.41e-05	0.000145	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.41e-05	0.000144	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—FGF2—malignant glioma	1.41e-05	0.000144	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HIF1A—malignant glioma	1.41e-05	0.000144	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.41e-05	0.000144	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTP1—malignant glioma	1.38e-05	0.000142	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—BRAF—malignant glioma	1.38e-05	0.000141	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—IDH2—malignant glioma	1.37e-05	0.000141	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTT1—malignant glioma	1.37e-05	0.000141	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.37e-05	0.000141	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.36e-05	0.000139	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CAV1—malignant glioma	1.36e-05	0.000139	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CAV1—malignant glioma	1.36e-05	0.000139	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KDR—malignant glioma	1.34e-05	0.000138	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CAT—malignant glioma	1.34e-05	0.000138	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT2—malignant glioma	1.34e-05	0.000137	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—EGFR—malignant glioma	1.34e-05	0.000137	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CD—malignant glioma	1.33e-05	0.000137	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PIK3CA—malignant glioma	1.32e-05	0.000135	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MDM2—malignant glioma	1.32e-05	0.000135	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RAF1—malignant glioma	1.31e-05	0.000134	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—BCHE—malignant glioma	1.31e-05	0.000134	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ERBB2—malignant glioma	1.3e-05	0.000133	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.3e-05	0.000133	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.3e-05	0.000133	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—FN1—malignant glioma	1.29e-05	0.000133	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—F2—malignant glioma	1.29e-05	0.000133	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.29e-05	0.000132	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CD—malignant glioma	1.29e-05	0.000132	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS1—malignant glioma	1.29e-05	0.000132	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.28e-05	0.000131	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CB—malignant glioma	1.28e-05	0.000131	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—BAD—malignant glioma	1.28e-05	0.000131	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PIK3CA—malignant glioma	1.28e-05	0.000131	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NCOR1—malignant glioma	1.27e-05	0.00013	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	1.27e-05	0.00013	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—KRAS—malignant glioma	1.26e-05	0.000129	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CD80—malignant glioma	1.24e-05	0.000127	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—APC—malignant glioma	1.24e-05	0.000127	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	1.24e-05	0.000127	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CG—malignant glioma	1.23e-05	0.000127	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—FGF2—malignant glioma	1.23e-05	0.000126	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCL8—malignant glioma	1.23e-05	0.000126	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.22e-05	0.000126	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGF—malignant glioma	1.22e-05	0.000126	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTPN11—malignant glioma	1.22e-05	0.000125	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.21e-05	0.000124	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—BCHE—malignant glioma	1.2e-05	0.000123	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPARG—malignant glioma	1.19e-05	0.000122	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AKT1—malignant glioma	1.19e-05	0.000122	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.19e-05	0.000122	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.18e-05	0.000121	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—IDH1—malignant glioma	1.18e-05	0.000121	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CASP3—malignant glioma	1.18e-05	0.000121	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL2—malignant glioma	1.18e-05	0.000121	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTP1—malignant glioma	1.17e-05	0.00012	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—BRAF—malignant glioma	1.16e-05	0.000119	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CB—malignant glioma	1.16e-05	0.000119	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CA—malignant glioma	1.16e-05	0.000119	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MDM2—malignant glioma	1.15e-05	0.000118	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RAF1—malignant glioma	1.15e-05	0.000118	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTGS2—malignant glioma	1.15e-05	0.000118	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SPHK1—malignant glioma	1.14e-05	0.000117	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ERBB2—malignant glioma	1.14e-05	0.000117	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CAT—malignant glioma	1.14e-05	0.000117	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT2—malignant glioma	1.13e-05	0.000116	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—EGFR—malignant glioma	1.13e-05	0.000116	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CB—malignant glioma	1.12e-05	0.000115	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.12e-05	0.000115	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.12e-05	0.000115	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MMP9—malignant glioma	1.11e-05	0.000114	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.11e-05	0.000113	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTEN—malignant glioma	1.11e-05	0.000113	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	1.09e-05	0.000112	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CD—malignant glioma	1.09e-05	0.000111	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AKT1—malignant glioma	1.08e-05	0.000111	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCL8—malignant glioma	1.08e-05	0.000111	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	1.08e-05	0.000111	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NCOR1—malignant glioma	1.07e-05	0.00011	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—KRAS—malignant glioma	1.07e-05	0.000109	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.06e-05	0.000109	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTP1—malignant glioma	1.04e-05	0.000107	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—FGF2—malignant glioma	1.04e-05	0.000107	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AKT1—malignant glioma	1.04e-05	0.000107	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CAV1—malignant glioma	1.03e-05	0.000106	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CASP3—malignant glioma	1.03e-05	0.000106	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL2—malignant glioma	1.03e-05	0.000106	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CAT—malignant glioma	1.02e-05	0.000104	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTEN—malignant glioma	1e-05	0.000103	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—malignant glioma	9.99e-06	0.000102	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STAT3—malignant glioma	9.9e-06	0.000101	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	9.79e-06	0.0001	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MMP9—malignant glioma	9.76e-06	0.0001	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MDM2—malignant glioma	9.75e-06	0.0001	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RAF1—malignant glioma	9.72e-06	9.97e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTEN—malignant glioma	9.7e-06	9.95e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.65e-06	9.89e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ERBB2—malignant glioma	9.62e-06	9.86e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NCOR1—malignant glioma	9.59e-06	9.83e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTP1—malignant glioma	9.51e-06	9.75e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	9.49e-06	9.73e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AKT1—malignant glioma	9.47e-06	9.71e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CB—malignant glioma	9.46e-06	9.7e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CG—malignant glioma	9.42e-06	9.66e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTGS2—malignant glioma	9.37e-06	9.61e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CAT—malignant glioma	9.26e-06	9.49e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MYC—malignant glioma	9.2e-06	9.43e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCL8—malignant glioma	9.12e-06	9.35e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARG—malignant glioma	9.09e-06	9.32e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTT1—malignant glioma	9.05e-06	9.28e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGFR—malignant glioma	8.99e-06	9.22e-05	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	8.81e-06	9.03e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—malignant glioma	8.76e-06	8.99e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CAV1—malignant glioma	8.76e-06	8.98e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NCOR1—malignant glioma	8.74e-06	8.96e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CASP3—malignant glioma	8.73e-06	8.95e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL2—malignant glioma	8.72e-06	8.94e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STAT3—malignant glioma	8.68e-06	8.9e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KRAS—malignant glioma	8.5e-06	8.71e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS1—malignant glioma	8.48e-06	8.7e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.37e-06	8.58e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CD—malignant glioma	8.28e-06	8.49e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MMP9—malignant glioma	8.25e-06	8.46e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTEN—malignant glioma	8.2e-06	8.41e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTEN—malignant glioma	8.18e-06	8.38e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MYC—malignant glioma	8.06e-06	8.27e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AKT1—malignant glioma	8e-06	8.2e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CG—malignant glioma	7.98e-06	8.18e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGFR—malignant glioma	7.89e-06	8.09e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—BCHE—malignant glioma	7.88e-06	8.08e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CAV1—malignant glioma	7.82e-06	8.01e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CA—malignant glioma	7.81e-06	8e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.79e-06	7.99e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARG—malignant glioma	7.7e-06	7.89e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—malignant glioma	7.55e-06	7.74e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.47e-06	7.66e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KRAS—malignant glioma	7.45e-06	7.64e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—malignant glioma	7.41e-06	7.59e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STAT3—malignant glioma	7.33e-06	7.52e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CB—malignant glioma	7.22e-06	7.4e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS2—malignant glioma	7.15e-06	7.33e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CAV1—malignant glioma	7.13e-06	7.31e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CG—malignant glioma	7.12e-06	7.3e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CA—malignant glioma	7.07e-06	7.25e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CD—malignant glioma	7.01e-06	7.19e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARG—malignant glioma	6.87e-06	7.04e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	6.84e-06	7.02e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MYC—malignant glioma	6.81e-06	6.99e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.81e-06	6.98e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGFR—malignant glioma	6.67e-06	6.83e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—malignant glioma	6.62e-06	6.79e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.49e-06	6.66e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT1—malignant glioma	6.38e-06	6.54e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KRAS—malignant glioma	6.3e-06	6.46e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTP1—malignant glioma	6.27e-06	6.43e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARG—malignant glioma	6.26e-06	6.42e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CD—malignant glioma	6.26e-06	6.42e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTEN—malignant glioma	6.24e-06	6.4e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CB—malignant glioma	6.11e-06	6.27e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CAT—malignant glioma	6.1e-06	6.26e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS2—malignant glioma	6.06e-06	6.21e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	5.78e-06	5.93e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKT1—malignant glioma	5.78e-06	5.93e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CA—malignant glioma	5.77e-06	5.91e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NCOR1—malignant glioma	5.77e-06	5.91e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.71e-06	5.85e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—malignant glioma	5.6e-06	5.74e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT1—malignant glioma	5.59e-06	5.73e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CB—malignant glioma	5.45e-06	5.59e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS2—malignant glioma	5.4e-06	5.54e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTEN—malignant glioma	5.28e-06	5.41e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.97e-06	5.1e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS2—malignant glioma	4.93e-06	5.05e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT1—malignant glioma	4.73e-06	4.85e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTEN—malignant glioma	4.71e-06	4.83e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKT1—malignant glioma	4.71e-06	4.83e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CAV1—malignant glioma	4.7e-06	4.82e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CA—malignant glioma	4.4e-06	4.51e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTEN—malignant glioma	4.3e-06	4.41e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.28e-06	4.39e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARG—malignant glioma	4.13e-06	4.24e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.76e-06	3.86e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.73e-06	3.82e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKT1—malignant glioma	3.59e-06	3.69e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CA—malignant glioma	3.33e-06	3.41e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.28e-06	3.36e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS2—malignant glioma	3.25e-06	3.33e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKT1—malignant glioma	3.04e-06	3.12e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.03e-06	3.11e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTEN—malignant glioma	2.83e-06	2.91e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKT1—malignant glioma	2.72e-06	2.79e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKT1—malignant glioma	2.48e-06	2.54e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CA—malignant glioma	2e-06	2.05e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKT1—malignant glioma	1.63e-06	1.67e-05	CbGpPWpGaD
